Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

The immune checkpoint based therapy targeting the programmed death-1 (PD-1) receptor and its PD-L1 ligand has recently been approved for the therapy of different malignant conditions, but not yet for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In this context, we evaluated the expressio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Sampedro-Núñez, Miguel, Serrano-Somavilla, Ana, Adrados, Magdalena, Cameselle-Teijeiro, José M., Blanco-Carrera, Concepción, Cabezas-Agricola, José Manuel, Martínez-Hernández, Rebeca, Martín-Pérez, Elena, Muñoz de Nova, José Luis, Díaz, José Ángel, García-Centeno, Rogelio, Caneiro-Gómez, Javier, Abdulkader, Ihab, González-Amaro, Roberto, Marazuela, Mónica
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292913/
https://ncbi.nlm.nih.gov/pubmed/30546030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-36129-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak